WO2021104252A1 - Kit for single-cell whole-genome amplification and use thereof - Google Patents

Kit for single-cell whole-genome amplification and use thereof Download PDF

Info

Publication number
WO2021104252A1
WO2021104252A1 PCT/CN2020/131099 CN2020131099W WO2021104252A1 WO 2021104252 A1 WO2021104252 A1 WO 2021104252A1 CN 2020131099 W CN2020131099 W CN 2020131099W WO 2021104252 A1 WO2021104252 A1 WO 2021104252A1
Authority
WO
WIPO (PCT)
Prior art keywords
amplification
cell
oil phase
oil
dna polymerase
Prior art date
Application number
PCT/CN2020/131099
Other languages
French (fr)
Chinese (zh)
Inventor
徐健
苏晓璐
籍月彤
荆晓艳
公衍海
Original Assignee
中国科学院青岛生物能源与过程研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国科学院青岛生物能源与过程研究所 filed Critical 中国科学院青岛生物能源与过程研究所
Publication of WO2021104252A1 publication Critical patent/WO2021104252A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the invention relates to a genome amplification method, a kit and its application.
  • the common method of single-cell genome sequencing requires the use of DNA polymerase and high-throughput short-tailed DNA sequencing to perform extensive in vitro amplification of the genome of a single cell.
  • These methods have two significant shortcomings. One is that polymerase replication errors may generate thousands of false positives, and the other is that relatively short sequence reads hardly contain any haplotype information.
  • single-cell research technology has some problems, such as amplification bias, non-specific amplification, low sensitivity, poor reproducibility, high operating error rate, and foreign contamination. For example, MDA is currently recognized as the best single-cell genome amplification technology.
  • MDA can perform high-fidelity and uniform amplification of the entire genome, amplifying fragments of 10 to 100 kb in size, and can provide a large number of uniform and complete genome sequences.
  • MDA also has some shortcomings, especially the significant non-specific amplification, and there is still amplification preference [9].
  • Single cell isolation technology will also affect genome amplification.
  • the laser radiation during Raman analysis and sorting will affect the physiological activity of cells. Cause certain damage [10].
  • the coverage of conventional bacterial single-cell sequencing after ejection generally does not exceed 20%, so genome assembly is relatively difficult [11,12].
  • how to improve the accuracy of amplification, coverage and convenient operation is the research direction of future scientific researchers.
  • the invention provides a method for amplifying the whole genome of a single cell, a kit and the application of the amplification method.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained from step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents for the amplification reaction are provided for the amplification reaction.
  • the method is applicable to single-cell samples of all species, for example, bacteria (gram-positive bacteria and gram-negative bacteria), plant cells, animal cells, etc.
  • the single cell sample includes, but is not limited to, cells resuspended in PBS, cells resuspended in water, cells resuspended in medium, cells fixed with acetaldehyde, and single cells directly isolated.
  • the other reagents necessary for the amplification reaction include DTT, DMSO, 10*phi29 buffer, dNTP, H2O, etc.
  • the DNA polymerase described in the present invention includes but is not limited to vent DNA polymerase, T7 DNA polymerase, T4 DNA polymerase, DNA polymerase I, (Klenow) large fragment, DNA polymerase I (E. coli), Sulfolobus DNA polymerase IV, phi29 DNA polymerase, Bst DNA polymerase, Equiphi29 DNA polymerase, etc., preferably Phi29 DNA polymerase.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction.
  • the oil phase includes one or more of mineral oil, fluorocarbon oil, and silane oil.
  • the oil phase is mineral oil.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction.
  • the oil phase includes one or more of mineral oil, fluorocarbon oil, and silane oil.
  • the oil phase SCC buffer O mainly includes mineral oil (light mineral oil, heavy mineral oil, etc.), fluorocarbon oil, and silanes.
  • the oil phase also contains a surfactant.
  • the surfactant is span-80 or EM90.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction.
  • the mixing ratio of the single cell sample and the oil phase is 1:0.5 to 1:20; preferably, the mixing ratio of the single cell sample and the oil phase is 1:1 to 1:10; more preferably, the mixing ratio of the single cell sample and the oil phase is 1:1 to 1:2.
  • the oil phase includes one or more of mineral oil, fluorocarbon oil, and silane oil.
  • the oil phase is mineral oil.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction.
  • the single cell sample to be amplified in a is a single cell suspended in water or PBS buffer.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction.
  • the single cell sample is a single cell obtained by laser radiation sorting, preferably, a single cell obtained by Raman signal sorting.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction. It is characterized in that, in step b, the method for lysing the cells is selected from any one of chemical lysis, enzymatic lysis, or mechanical lysis or any combination thereof.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a resuspend the single-cell sample to be amplified in an oil phase; b. Cells suspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction. It is characterized in that, in step b, the cell is lysed by chemical lysis, preferably alkaline lysis is used.
  • the alkaline lysis solution is composed of Lysis buffer A1 and DTT;
  • the Lysis buffer A1 is composed of a solute and a solvent;
  • the solvent is water;
  • the solute and its concentration are: 0.09-0.11mM KOH and 0.9 -1.1mM EDTA;
  • the Lysis buffer A1 is composed of a solute and a solvent;
  • the solvent is water;
  • the solute and its concentration are: 0.1mM KOH and 1mM EDTA;
  • the DTT is composed of a solute and a solvent;
  • the solvent is water; solute Its concentration is: 0.1-5M DTT.
  • the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction. In step c, the DNA polymerase is Phi29 DNA polymerase, or Equiphi29 (Thermo Fisher).
  • the present invention also provides a single-cell whole-genome amplification kit, which is characterized in that the kit includes a pretreatment solution for single-cell sample amplification, DNA polymerase, amplification buffer, and primers; the single-cell
  • the pretreatment liquid before sample amplification is oil.
  • the DNA polymerase is Phi29 DNA polymerase, or Equiphi29 (Thermo Fisher).
  • the present invention provides a single-cell whole-genome amplification kit, characterized in that the kit includes a pre-treatment solution for single-cell sample amplification, DNA polymerase, amplification buffer, and primers;
  • the pretreatment liquid before single cell sample amplification is an oil phase.
  • the oil in the sample pretreatment liquid before single cell sample amplification is selected from one or more of mineral oil, fluorocarbon oil, and silane oil .
  • the pretreatment solution before single-cell sample expansion further contains a surfactant.
  • the surfactant is span-80 or EM90.
  • the kit also contains instructions.
  • the present invention also protects another single-cell genome amplification method, which includes the following steps:
  • the oil solution SCC buffer O solution contains one or more of mineral oil, fluorocarbon oil, and silane oil;
  • step (2) Add 1 ⁇ l of denatured lysate Lysis buffer A to the solution obtained in step (1), shake and mix thoroughly, centrifuge briefly, and then incubate at 65°C for 10-15min;
  • the denatured lysis solution Lysis buffer A is composed of Lysis buffer A1 and DTT;
  • the Lysis buffer A1 is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 0.09-0.11mM KOH and 0.9-1.1mM EDTA;
  • the DTT is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 0.1-5M DTT;
  • step (3) Add 1 ⁇ l of Neutralization buffer B to the solution obtained in step (2), shake and mix thoroughly, and centrifuge briefly to obtain a template solution, and store on ice;
  • the neutralization buffer B is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 54-66mM KH2PO4 and 4.5-5.5mM K2HPO4;
  • step (3) Take 3 ⁇ L of the template solution obtained in step (3), add 10 ⁇ L of the reaction mixture, incubate at 30°C for 8 hours, and then stand at 65°C for 10 minutes to obtain the amplified product;
  • the reaction mixture is composed of 2.25 ⁇ l water, 7.25 ⁇ l SCC-reaction buffer C 1 solution and 0.5 ⁇ l DNA polymerase;
  • the SCC-reaction buffer C1 solution consists of 1 ⁇ l 10 ⁇ Phi29 buffer, 4.54 ⁇ l water, 0.75 ⁇ l DMSO, and 0.96 ⁇ l amplification system A;
  • a single amplification system A consists of 0.06 ⁇ l dNTP, 0.75 ⁇ l N6primers and 0.15 ⁇ l DTT; the N6primers are random primers composed of 6 deoxyribonucleotides, A, G, C and T are randomly arranged, and the 3′ end Two kinds of nucleotides are modified with phosphosulfate;
  • the concentration of dATP/dTTP/dCTP/dGTP is 10 mM; in the N6primers solution, the total primer concentration is 50 ⁇ M;
  • the DNA polymerase is 0.5 ⁇ L Phi29 DNA polymerase
  • the concentration of the Phi29 DNA polymerase is 10 U/ ⁇ L.
  • the present invention also provides the application of any of the above methods in genome sequencing, holographic array, quantitative PCR and the like.
  • genome sequencing is second-generation sequencing.
  • the present invention also provides the application of any of the above kits in genome sequencing, holographic array, quantitative PCR and the like.
  • genome sequencing is second-generation sequencing.
  • the kit provided by the present invention can be used for single cell samples of all species, for example, bacteria (Gram-positive bacteria and Gram-negative bacteria), sorted or tissue cultured animal cells, plant cells, etc.
  • the kit can be applied to the functional research of complex microbial communities and bacterial infections, and has great application prospects and promotion value.
  • the present invention provides a single-cell whole-genome amplification method that can improve genome coverage.
  • the method performs high-fidelity and high-uniform amplification of different sites in the whole genome of a single cell, and the amplified products can be used for high-throughput sequencing analysis.
  • the present invention provides kits for single cell amplification, existing amplification methods and single cell kits (commonly used Qiagen single cell kit), and genome coverage obtained by single cell amplification after Raman measurement The rate is relatively low.
  • This kit can significantly reduce the deviation caused by the amplification process, and has a highly efficient and stable amplification effect, which can significantly increase the genome coverage of single-cell amplification, and can provide more than 90% of the genome from a single cell DNA sequence information.
  • Lysis buffer A1 is 0.1mM KOH, 1mM EDTA, mix in the following proportions when using
  • the temperature of the thermal lid of the PCR machine is set to 70°C.
  • E. coli cell material includes but not limited to cells resuspended in PBS, cells resuspended in water, cells resuspended in culture medium, cells fixed with acetaldehyde, single cells directly isolated, etc. Put it in a microcentrifuge tube, add 0.5 to 20 times the sample volume of mineral oil (1 times is better), shake and mix thoroughly.
  • Enzymatic lysis such as lysozyme lysis, has the same effect of mechanical lysis and chemical lysis.
  • the enzymatic lysis includes but is not limited to SDS and lysozyme, the mechanical lysis includes heat shock and ultrasonic lysis, and the working method of the ultrasonic lysis is at a lysis power of 300-400w, each time it works intermittently after 2-5s 4 ⁇ 10s, total working time is 6 ⁇ 10min.
  • Neutralization buffer B with the same volume as Lysis buffer.
  • Neutralization buffer B is configured by 60mM KH2PO4 and 5mM K2HPO4. Shake well and mix well, centrifuge briefly, and store on ice.
  • DNA polymerases include but are not limited to vent DNA polymerase, T7 DNA polymerase, T4 DNA polymerase, DNA polymerase I, (Klenow) large fragments, DNA polymerase I (E.coli), Sulfolobus DNA polymerase IV, phi29 DNA polymerase, Bst DNA polymerase, Equiphi29 DNA polymerase, etc., the best is Phi29 DNA polymerase.
  • SCC-reaction buffer C1 solution can be 10% by volume 10 ⁇ It consists of Phi29buffer, water, 7.5% DMSO by volume, 10mM dNTP, N6primers with a total primer concentration of 50 ⁇ M, and 1M DTT.
  • the amplification mixture can be prepared according to Table 2. After water (ddH 2 O), SCC-reaction buffer C 1 , shake and mix well and centrifuge, then add Phi29 DNA polymerase.
  • the amplified DNA was diluted 20 times, and 1 ⁇ l of the reaction was used as a template.
  • the bacterial gene fragments were successfully amplified in the samples pre-treated with the oil phase, and no contamination was found.
  • the MDA reaction yielded 732-3,600ng product, which is sufficient for subsequent next-generation sequencing preparation.
  • 10 single amplified genomes were obtained (5 contained oily phase when amplified and 5 did not contain) (Table 3).
  • the genome coverage rate obtained under the standard amplification conditions of the oil-free pretreatment sample was 49.82%-52.60%, while the genome coverage rate of the sample amplified by the oil-phase pretreatment sample was significantly higher, 89.78% to 99.97% .
  • Phi29DNA polymerase is placed on ice for use; other reagents need to be dissolved at room temperature before being shaken and centrifuged, and placed on ice for use; ddH 2 O is placed at room temperature for use; the amplification mixture can be prepared according to Table 4. After water (ddH 2 O), SCC-reaction buffer C 1 , shake and mix well and centrifuge, then add Phi29 DNA polymerase.
  • the amplified DNA was diluted 20 times, and 1 ⁇ l of the reaction was used as a template.
  • the bacterial gene fragments were successfully amplified in the oil-phase pretreated samples, and no contamination was found.
  • the MDA reaction yielded 998-4,020ng product, which is enough for subsequent next-generation sequencing preparation.
  • the library was constructed using 5 samples pretreated with oil phase and 5 samples without oil phase pretreatment for amplification and sequencing with Illumina HiSeq2500. Through assembly, 10 single amplified genomes were obtained (Table 5).
  • the genome coverage of samples without oil phase pretreatment under standard amplification conditions is 55.67%-67.80%, while the genome coverage of samples amplified by oil phase pretreatment samples is significantly higher, reaching 93.19% ⁇ 99.89%.
  • the amplified DNA was diluted 20 times, and 1 ⁇ l of the reaction was used as a template.
  • the library was constructed and sequenced with Illumina HiSeq2500. Through assembly, 10 single amplified genomes were obtained (5 contained oily phase when amplified, 5 did not contain) (Table 6). The genome coverage rate obtained under standard amplification conditions without oil phase was 49.02%-57.60%, while the genome coverage rate obtained from the oily phase amplified samples was significantly higher, ranging from 92.18% to 99.57%.
  • step 1 Except that in step 1, the mineral oil is replaced with fluorocarbon oil, the other steps are the same as in Example 5. The results showed that the genome coverage of the oil-containing amplified samples was significantly higher than that of the control.

Abstract

The present invention relates to a method and a kit for genome amplification and the use thereof. Disclosed is a method for single-cell whole-genome amplification, the method comprising the following steps: a. resuspending a single-cell sample to be amplified in an oil phase; b. lysing the cells, which are resuspended in the oil phase, obtained in step a; and c. introducing DNA polymerase, primers, and other reagents necessary for an amplification reaction into the sample obtained in step b so as to perform an amplification reaction. Also disclosed are an amplification kit, and the uses of the above-mentioned amplification method and the amplification kit. The disclosed amplification method and kit can reduce deviation caused during an amplification process, have a highly efficient and stable amplification effect, and can improve the genome coverage of single-cell amplification.

Description

单细胞全基因组扩增试剂盒及其应用Single cell whole genome amplification kit and its application 技术领域Technical field
本发明涉及一种基因组扩增方法,试剂盒及其应用。The invention relates to a genome amplification method, a kit and its application.
背景技术Background technique
DNA测序技术的快速发展使得学术界对包括人类在内的各类物种的基因组有了更全面的认识,下一代测序的全基因组扩增(whole-genome amplification,WGA)在生物学和医学领域都有广泛的应用。随着测序技术、单细胞分离技术和全基因组扩增技术的快速发展,单细胞研究技术被列为未来几年最值得关注的技术之一。在单细胞水平上对基因组进行测序能更好地解决传统技术的局限性问题。单细胞全基因组扩增技术的难点在于单细胞的分离和全基因组的扩增。单细胞全基因组扩增技术是进行单细胞测序的前提,该技术可用于揭示单细胞基因组结构差异。The rapid development of DNA sequencing technology has enabled the academic community to have a more comprehensive understanding of the genomes of various species, including humans. The whole-genome amplification (WGA) of next-generation sequencing is used in biology and medicine. There are a wide range of applications. With the rapid development of sequencing technology, single cell separation technology and whole genome amplification technology, single cell research technology is listed as one of the most noteworthy technologies in the next few years. Sequencing the genome at the single-cell level can better solve the limitations of traditional technologies. The difficulty of single-cell whole-genome amplification technology lies in the isolation of single-cell and whole-genome amplification. Single-cell whole-genome amplification technology is the prerequisite for single-cell sequencing, and this technology can be used to reveal structural differences in single-cell genomes.
单细胞基因组测序常见的方法需要使用DNA聚合酶和高通量的短尾DNA测序,对单个细胞的基因组进行广泛的体外扩增。这些方法有两个显著的缺点,一是聚合酶复制错误可能会产生成千上万的假阳性,二是相对较短的序列读取几乎不包含任何单倍类型的信息。此外,单细胞研究技术存在一些问题,如扩增偏倚性、非特异性扩增、灵敏度不高、重复性差、操作失误率高、存在外来污染等。例如,MDA是目前公认的最好的单细胞基因组扩增技术,它能对全基因组进行高保真的均匀扩增,扩增出10~100kb大小的片段,能提供大量均一完整的全基因组序列。但是MDA也有一些缺点,特别是显著的非特异扩增,另外就是仍然存在扩增偏好性[9]。The common method of single-cell genome sequencing requires the use of DNA polymerase and high-throughput short-tailed DNA sequencing to perform extensive in vitro amplification of the genome of a single cell. These methods have two significant shortcomings. One is that polymerase replication errors may generate thousands of false positives, and the other is that relatively short sequence reads hardly contain any haplotype information. In addition, single-cell research technology has some problems, such as amplification bias, non-specific amplification, low sensitivity, poor reproducibility, high operating error rate, and foreign contamination. For example, MDA is currently recognized as the best single-cell genome amplification technology. It can perform high-fidelity and uniform amplification of the entire genome, amplifying fragments of 10 to 100 kb in size, and can provide a large number of uniform and complete genome sequences. However, MDA also has some shortcomings, especially the significant non-specific amplification, and there is still amplification preference [9].
单细胞分离技术也会对基因组扩增造成影响。研究表明,细菌细胞在单细胞拉曼微谱学分析过程中,直接激光照射后,其膜完整性会丧失,甚至导致大量细胞死亡,拉曼分析分选时的激光辐射对细胞的生理活性会造成一定损伤[10]。此外,由于激光辐射引起胞内核酸损伤等可能原因,弹射后常规细菌单细胞测序的覆盖度一般不超过20%,因此基因组拼装相对困难[11,12]。针对这些问题,如何提高扩增准确性、覆盖率和操作便捷是未来科研工作者的研究方向。Single cell isolation technology will also affect genome amplification. Studies have shown that in the process of single-cell Raman microspectroscopy analysis of bacterial cells, after direct laser irradiation, their membrane integrity will be lost, and even a large number of cells will die. The laser radiation during Raman analysis and sorting will affect the physiological activity of cells. Cause certain damage [10]. In addition, due to possible causes such as intracellular nucleic acid damage caused by laser radiation, the coverage of conventional bacterial single-cell sequencing after ejection generally does not exceed 20%, so genome assembly is relatively difficult [11,12]. In response to these problems, how to improve the accuracy of amplification, coverage and convenient operation is the research direction of future scientific researchers.
1.Assmann C,Kirchhoff J,Beleites C,Hey J,Kostudis S,Pfister W,et al.Identification of vancomycin interaction with Enterococcus faecalis within 30min of interaction time using Raman spectroscopy.Anal Bioanal Chem 2015;407(27):8343-8352.1. Assmann C, Kirchhoff J, Belites C, Hey J, Kostudis S, Pfister W, et al. Identification of vancomycin interaction with Enterococcus faecalis with in 30min of interaction: time using Raman spectrosal. 834 3 (copy 27 Bioan) 2015; -8352.
2.Schroder UC,Beleites C,Assmann C,Glaser U,Hubner U,Pfister W,et al.Detection of vancomycin resistances in enterococci within 3 1/2 hours.Sci Rep-Uk 2015;5.2. Schroder UC, Belites C, Assmann C, Glaser U, Hubner U, Pfister W, et al. Detection of vancomycin resistances in enterococci within 3 1/2 hours. Sci Rep-Uk 2015; 5.
3.Teng L,Wang X,Wang X,Gou H,Ren L,Wang T,et al.Label-free,rapid and quantitative phenotyping of stress response in E.coli via ramanome.Sci Rep 2016;6:34359.3.Teng L, Wang X, Wang X, Gou H, Ren L, Wang T, et al. Label-free, rapid and quantitative phenotyping of stress response in E. coli via ramanome. Sci Rep 2016; 6:34359.
4.Gruber-Vodicka HR,Dirks U,Leisch N,Baranyi C,Stoecker K,Bulgheresi S,et al.Paracatenula,an ancient symbiosis between thiotrophic Alphaproteobacteria and catenulid flatworms.P Natl Acad Sci USA 2011;108(29):12078-12083.4. Gruber-Vodicka HR, Dirks U, Leisch N, Baranyi C, Stoecker K, Bulgheresi S, et al. Paracatenula, an ancient symbiosis between thiotrophic Alphaproteobacteria and catenulid (USA 29)worms. P Natl 29 (USA) 78 worms. -12083.
5.Briers Y,Staubli T,Schmid MC,Wagner M,Schuppler M,Loessner MJ.Intracellular Vesicles as Reproduction Elements in Cell Wall-Deficient L-Form Bacteria.Plos One 2012;7(6).5. Briers Y, Staubli T, Schmid MC, Wagner M, Schuppler M, Loessner MJ. Intracellular Vesicles as Reproduction Elements in Cell Wall-Deficient L-Form Bacteria. Plos One 2012; 7(6).
6.Majed N,Chernenko T,Diem M,Gu AZ.Identification of Functionally Relevant Populations in Enhanced Biological Phosphorus Removal Processes Based On Intracellular Polymers Profiles and Insights into the Metabolic Diversity and Heterogeneity.Environ Sci Technol 2012;46(9):5010-5017.6. Majed N, Chernenko T, Diem M, Gu AZ.Identification of Functionally Relevant Populations in Enhanced Biological Phosphorus Removal Processes Based On Intracellular Polymers Profiles and Insights Into the Diversity 10; Technological Heterogenity 46; -5017.
7.Milucka J,Ferdelman TG,Polerecky L,Franzke D,Wegener G,Schmid M,et al.Zero-valent sulphur is a key intermediate in marine methane oxidation.Nature 2012;491(7425):541-+.7.Milucka J, Ferdelman TG, Polerecky L, Franzke D, Wegener G, Schmid M, et al. Zero-valent sulphur is a key intermediate in marine methane oxidation. Nature 2012; 491(7425): 541-+.
8.Li MQ,Canniffe DP,Jackson PJ,Davison PA,FitzGerald S,Dickman MJ,et al.Rapid resonance Raman microspectroscopy to probe carbon dioxide fixation by single cells in microbial communities.Isme Journal 2012;6(4):875-8858.Li MQ, Canniffe DP, Jackson PJ, Davison PA, FitzGerald S, Dickman MJ, et al. Rapid resonance to probe carbon dioxide fixation by single cells in microbial communities.Isme: 875 885
9 Woyke,T.,D.F.R.Doud,and F.Schulz,The trajectory of microbial single-cell sequencing.Nat Methods,2017. 14(11):p.1045-1054.9 Woyke, T., D.F.R. Doud, and F. Schulz, The trajectory of microbial single-cell sequencing. Nat Methods, 2017. 14(11): p.1045-1054.
10 Mathey,R.,et al.,Viability of 3h grown bacterial micro-colonies after direct Raman identification.J Microbiol Methods,2015.109:p.67-73.10 Mathey, R., et al., Viability of 3h grown bacterial micro-colonies after direct Raman identification. J Microbiol Methods, 2015.109: p. 67-73.
11 Jing X,Gou H,Gong Y,et al.Raman-activated cell sorting and metagenomic sequencing revealing carbon-fixing bacteria in the ocean.Environment Microbiology,2018,4:29727057.11 Jing X, Gou H, Gong Y, et al. Raman-activated cell sorting and metagenomic sequencing revealing carbon-fixing bacteria in the ocean. Environment Microbiology, 2018, 4: 29727057.
12 Song Y,Kaster A K,Vollmers J,et al.Single-cell genomics based on Raman sorting reveals novel carotenoid-containing bacteria in the Red Sea.Microbal Biotechnology,2017,10(1):125-137.12 Song Y, Kaster A K, Vollmers J, et al. Single-cell genomics based on Raman sorting reveals novel carotenoid-containing bacteria in the Red Sea. Microbal Biotechnology, 2017, 10(1): 125-137.
13 Yuan X,Song Y,Song Y,et al.Effect of laser irradiation on cell function and its implications in Raman Spectroscopy.Applied and Environmental Microbiology,2018,84(8):e02508-17.13 Yuan X, Song Y, Song Y, et al. Effect of laser irradiation on cell function and its implications in Raman Spectroscopy. Applied and Environmental Microbiology, 2018, 84(8): e02508-17.
发明内容Summary of the invention
本发明提供了一种单细胞全基因组扩增的方法,试剂盒以及本扩增方法的应用。The invention provides a method for amplifying the whole genome of a single cell, a kit and the application of the amplification method.
一方面,本发明提供了一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他扩增反应必需的试剂进行扩增反应。In one aspect, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained from step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents for the amplification reaction are provided for the amplification reaction.
所述方法适用于所有物种的单细胞样本,例如,细菌(革兰氏阳性菌和革兰氏阴性菌)、植物细胞、动物细胞等。The method is applicable to single-cell samples of all species, for example, bacteria (gram-positive bacteria and gram-negative bacteria), plant cells, animal cells, etc.
所述的单细胞样本包括但不限于PBS重悬的细胞,水重悬的细胞,培养基重悬的细胞,乙醛固定的细胞和直接分离的单个细胞。The single cell sample includes, but is not limited to, cells resuspended in PBS, cells resuspended in water, cells resuspended in medium, cells fixed with acetaldehyde, and single cells directly isolated.
所述的其他扩增反应必需的试剂包括DTT,DMSO,10*phi29 buffer,dNTP,H2O等The other reagents necessary for the amplification reaction include DTT, DMSO, 10*phi29 buffer, dNTP, H2O, etc.
本发明中所述的DNA聚合酶包括但不限于vent DNA聚合酶、T7 DNA聚合酶、T4 DNA聚合酶、DNA聚合酶I、(Klenow)大片段、DNA聚合酶I(E.coli)、Sulfolobus DNA聚合酶IV、phi29 DNA聚合酶、Bst DNA聚合酶,Equiphi29 DNA聚合酶等,优选的为Phi29 DNA聚合酶。The DNA polymerase described in the present invention includes but is not limited to vent DNA polymerase, T7 DNA polymerase, T4 DNA polymerase, DNA polymerase I, (Klenow) large fragment, DNA polymerase I (E. coli), Sulfolobus DNA polymerase IV, phi29 DNA polymerase, Bst DNA polymerase, Equiphi29 DNA polymerase, etc., preferably Phi29 DNA polymerase.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。所述油相包含矿物油,氟碳油,硅烷油中的一种或多种。优选的,油相为矿物油。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction. The oil phase includes one or more of mineral oil, fluorocarbon oil, and silane oil. Preferably, the oil phase is mineral oil.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油 相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。所述油相包含矿物油,氟碳油,硅烷油中的一种或多种。所述油相SCC buffer O主要包括矿物油(轻质矿物油和重质矿物油等),氟碳油,硅烷类的。所述油相还包含表面活性剂,优选的,表面活性剂是span-80或EM90。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction. The oil phase includes one or more of mineral oil, fluorocarbon oil, and silane oil. The oil phase SCC buffer O mainly includes mineral oil (light mineral oil, heavy mineral oil, etc.), fluorocarbon oil, and silanes. The oil phase also contains a surfactant. Preferably, the surfactant is span-80 or EM90.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。单细胞样本与油相混合比例为1:0.5至1:20;优选地,单细胞样本与油相混合比例为1:1至1:10;更优选的,单细胞样本与油相混合比例为1:1至1:2。所述油相包含矿物油,氟碳油,硅烷油中的一种或多种。优选的,油相为矿物油。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction. The mixing ratio of the single cell sample and the oil phase is 1:0.5 to 1:20; preferably, the mixing ratio of the single cell sample and the oil phase is 1:1 to 1:10; more preferably, the mixing ratio of the single cell sample and the oil phase is 1:1 to 1:2. The oil phase includes one or more of mineral oil, fluorocarbon oil, and silane oil. Preferably, the oil phase is mineral oil.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。所述a中待扩增的单细胞样本为单细胞悬于水或PBS缓冲液。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction. The single cell sample to be amplified in a is a single cell suspended in water or PBS buffer.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。所述的单细胞样本是通过激光辐射分选获得的单细胞,优选的,拉曼信号分选获得的单细胞。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction. The single cell sample is a single cell obtained by laser radiation sorting, preferably, a single cell obtained by Raman signal sorting.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。其特征在于,b步骤中,对细胞进行裂解的方式选自化学裂解、酶裂解或机械裂解的任一种或其任意组合。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction. It is characterized in that, in step b, the method for lysing the cells is selected from any one of chemical lysis, enzymatic lysis, or mechanical lysis or any combination thereof.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应。其特征在于,b步骤中,对细胞进行裂解的方式为化学裂解,优选地,采用碱裂解。更优选的,所述碱裂解液(Lysis buffer A)由Lysis  buffer A1和DTT组成;所述Lysis buffer A1由溶质和溶剂组成;溶剂为水;溶质及其浓度为:0.09-0.11mM KOH和0.9-1.1mM EDTA;优选的,所述Lysis buffer A1由溶质和溶剂组成;溶剂为水;溶质及其浓度为:0.1mM KOH和1mM EDTA;所述DTT由溶质和溶剂组成;溶剂为水;溶质及其浓度为:0.1-5M DTT。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a resuspend the single-cell sample to be amplified in an oil phase; b. Cells suspended in the oil phase are lysed; c. In the sample obtained in step b above, DNA polymerase, primers, and other necessary reagents are provided for the amplification reaction. It is characterized in that, in step b, the cell is lysed by chemical lysis, preferably alkaline lysis is used. More preferably, the alkaline lysis solution (Lysis buffer A) is composed of Lysis buffer A1 and DTT; the Lysis buffer A1 is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 0.09-0.11mM KOH and 0.9 -1.1mM EDTA; preferably, the Lysis buffer A1 is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 0.1mM KOH and 1mM EDTA; the DTT is composed of a solute and a solvent; the solvent is water; solute Its concentration is: 0.1-5M DTT.
另一方面,本发明提供一种单细胞全基因组扩增的方法,其特征在于包括以下步骤:a.将待扩增的单细胞样本重悬于油相中;b.将上述a步骤获得的重悬于油相的细胞进行裂解;c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他必需的试剂进行扩增反应,c步骤中DNA聚合酶是Phi29 DNA聚合酶,或Equiphi29(Thermo Fisher)。On the other hand, the present invention provides a single-cell whole-genome amplification method, which is characterized by comprising the following steps: a. Resuspend the single-cell sample to be amplified in an oil phase; b. Obtained in step a above Cells resuspended in the oil phase are lysed; c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction. In step c, the DNA polymerase is Phi29 DNA polymerase, or Equiphi29 (Thermo Fisher).
本发明还提供了一种单细胞全基因组扩增试剂盒,其特征在于,所述试剂盒包括单细胞样本扩增前预处理液,DNA聚合酶,扩增缓冲液,引物;所述单细胞样本扩增前预处理液为油。优选的,DNA聚合酶是Phi29DNA聚合酶,或Equiphi29(Thermo Fisher)。The present invention also provides a single-cell whole-genome amplification kit, which is characterized in that the kit includes a pretreatment solution for single-cell sample amplification, DNA polymerase, amplification buffer, and primers; the single-cell The pretreatment liquid before sample amplification is oil. Preferably, the DNA polymerase is Phi29 DNA polymerase, or Equiphi29 (Thermo Fisher).
另一方面,本发明提供了一种单细胞全基因组扩增试剂盒,其特征在于,所述试剂盒包括单细胞样本扩增前预处理液,DNA聚合酶,扩增缓冲液,引物;所述单细胞样本扩增前预处理液为油相,优选的,单细胞样本扩增前样本预处理液中的油选自矿物油,氟碳油,硅烷类的油中的一种或多种。In another aspect, the present invention provides a single-cell whole-genome amplification kit, characterized in that the kit includes a pre-treatment solution for single-cell sample amplification, DNA polymerase, amplification buffer, and primers; The pretreatment liquid before single cell sample amplification is an oil phase. Preferably, the oil in the sample pretreatment liquid before single cell sample amplification is selected from one or more of mineral oil, fluorocarbon oil, and silane oil .
优选的,单细胞样本扩增前预处理液还包含表面活性剂,优选的,表面活性剂是span-80或EM90。Preferably, the pretreatment solution before single-cell sample expansion further contains a surfactant. Preferably, the surfactant is span-80 or EM90.
优选的,试剂盒还包含说明书。Preferably, the kit also contains instructions.
本发明还保护另一种单细胞基因组扩增的方法,包括如下步骤:The present invention also protects another single-cell genome amplification method, which includes the following steps:
(1)将0.5μl细胞材料(PBS重悬)放到微型离心管中,加入1μl油溶液SCC buffer O,充分震荡混匀;(1) Put 0.5μl of cell material (resuspended in PBS) into a microcentrifuge tube, add 1μl of oil solution SCC buffer O, shake and mix thoroughly;
所述油溶液SCC buffer O溶液包含矿物油,氟碳油,硅烷油中的一种或多种;The oil solution SCC buffer O solution contains one or more of mineral oil, fluorocarbon oil, and silane oil;
(2)将1μl变性裂解液Lysis buffer A加入步骤(1)所得溶液,充分震荡混匀,并短暂离心,随后65℃孵育10-15min;(2) Add 1μl of denatured lysate Lysis buffer A to the solution obtained in step (1), shake and mix thoroughly, centrifuge briefly, and then incubate at 65°C for 10-15min;
所述变性裂解液Lysis buffer A由Lysis buffer A1和DTT组成;The denatured lysis solution Lysis buffer A is composed of Lysis buffer A1 and DTT;
所述Lysis buffer A1由溶质和溶剂组成;溶剂为水;溶质及其浓度为:0.09-0.11mM KOH和0.9-1.1mM EDTA;The Lysis buffer A1 is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 0.09-0.11mM KOH and 0.9-1.1mM EDTA;
所述DTT由溶质和溶剂组成;溶剂为水;溶质及其浓度为:0.1-5M DTT;The DTT is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 0.1-5M DTT;
(3)向步骤(2)所得溶液加入1μl中和缓冲液Neutralization buffer B, 充分震荡混匀,并短暂离心,得到模板溶液,冰上储存;(3) Add 1μl of Neutralization buffer B to the solution obtained in step (2), shake and mix thoroughly, and centrifuge briefly to obtain a template solution, and store on ice;
所述中和缓冲液Neutralization buffer B由溶质和溶剂组成;溶剂为水;溶质及其浓度为:54-66mM KH2PO4和4.5-5.5mM K2HPO4;The neutralization buffer B is composed of a solute and a solvent; the solvent is water; the solute and its concentration are: 54-66mM KH2PO4 and 4.5-5.5mM K2HPO4;
(4)取步骤(3)所得模板溶液3μL,加入10μL反应混合液,30℃孵育8小时,随后65℃静置10min,得到扩增产物;(4) Take 3 μL of the template solution obtained in step (3), add 10 μL of the reaction mixture, incubate at 30°C for 8 hours, and then stand at 65°C for 10 minutes to obtain the amplified product;
所述反应混合液由2.25μl水、7.25μl SCC-reaction buffer C 1溶液和0.5μl DNA聚合酶组成; The reaction mixture is composed of 2.25 μl water, 7.25 μl SCC-reaction buffer C 1 solution and 0.5 μl DNA polymerase;
所述SCC-reaction buffer C1溶液由1μl 10×Phi29buffer、4.54μl水、0.75μl DMSO和0.96μl扩增体系甲组成;The SCC-reaction buffer C1 solution consists of 1 μl 10×Phi29 buffer, 4.54 μl water, 0.75 μl DMSO, and 0.96 μl amplification system A;
单份扩增体系甲由0.06μl dNTP、0.75μl N6primers和0.15μl DTT组成;所述N6primers为随机引物,由6个脱氧核糖核苷酸组成,A、G、C和T随机排列,3′末端两种核苷酸进行磷代硫酸酯修饰;A single amplification system A consists of 0.06μl dNTP, 0.75μl N6primers and 0.15μl DTT; the N6primers are random primers composed of 6 deoxyribonucleotides, A, G, C and T are randomly arranged, and the 3′ end Two kinds of nucleotides are modified with phosphosulfate;
所述dNTP溶液中,dATP/dTTP/dCTP/dGTP的浓度均为10mM;所述N6primers溶液中,引物总浓度为50μM;In the dNTP solution, the concentration of dATP/dTTP/dCTP/dGTP is 10 mM; in the N6primers solution, the total primer concentration is 50 μM;
所述DNA聚合酶为0.5μL Phi29DNA聚合酶;The DNA polymerase is 0.5 μL Phi29 DNA polymerase;
所述Phi29DNA聚合酶的浓度为10U/μL。The concentration of the Phi29 DNA polymerase is 10 U/μL.
本发明还提供了上述任一方法在基因组测序、全息阵列、定量PCR等中的应用。优选的,基因组测序是二代测序。The present invention also provides the application of any of the above methods in genome sequencing, holographic array, quantitative PCR and the like. Preferably, genome sequencing is second-generation sequencing.
本发明还提供了以上任一所述试剂盒的在基因组测序,全息阵列,定量PCR等中的应用。优选的,基因组测序是二代测序。The present invention also provides the application of any of the above kits in genome sequencing, holographic array, quantitative PCR and the like. Preferably, genome sequencing is second-generation sequencing.
本发明所提供试剂盒可用于所有物种的单细胞样本,例如,细菌(革兰氏阳性菌和革兰氏阴性菌),分选的或组织培养的动物细胞、植物细胞等。试剂盒可应用于复杂微生物群落和细菌感染等疾病的功能研究,具有重大的应用前景和推广价值。The kit provided by the present invention can be used for single cell samples of all species, for example, bacteria (Gram-positive bacteria and Gram-negative bacteria), sorted or tissue cultured animal cells, plant cells, etc. The kit can be applied to the functional research of complex microbial communities and bacterial infections, and has great application prospects and promotion value.
第一方面,本发明提供了一种能够提高基因组覆盖度的单细胞全基因组扩增方法。该方法对单细胞全基因组的各不同位点进行高保真,高均一的扩增,扩增物可用于高通量测序分析。In the first aspect, the present invention provides a single-cell whole-genome amplification method that can improve genome coverage. The method performs high-fidelity and high-uniform amplification of different sites in the whole genome of a single cell, and the amplified products can be used for high-throughput sequencing analysis.
第二方面,本发明提供了用于单细胞扩增的试剂盒,现有的扩增方法及单细胞试剂盒(常用Qiagen single cell kit),拉曼测量后的单细胞扩增得到的基因组覆盖率都比较低,该试剂盒可以显著降低扩增过程中造成的偏差,具有高效稳定扩增效果,从而能显著地提高单细胞扩增的基因组覆盖度,能从单细胞提供出90 %以上基因组DNA序列信息。In the second aspect, the present invention provides kits for single cell amplification, existing amplification methods and single cell kits (commonly used Qiagen single cell kit), and genome coverage obtained by single cell amplification after Raman measurement The rate is relatively low. This kit can significantly reduce the deviation caused by the amplification process, and has a highly efficient and stable amplification effect, which can significantly increase the genome coverage of single-cell amplification, and can provide more than 90% of the genome from a single cell DNA sequence information.
具体实施方式Detailed ways
以下具体实施例是对本发明提供的方法与技术方案的进一步说明,但不应理解成对本发明的限制。The following specific examples are further descriptions of the methods and technical solutions provided by the present invention, but should not be construed as limiting the present invention.
实施例1、试剂准备Example 1. Preparation of reagents
1.准备充足的裂解液(Lysis buffer A)用于单细胞基因组扩增反应过程(表1);1. Prepare sufficient lysis buffer (Lysis buffer A) for the single-cell genome amplification reaction process (Table 1);
表1 Lysis buffer A配制:Lysis buffer A1为0.1mM KOH、1mM EDTA,使用时按下列比例混合Table 1 Preparation of Lysis buffer A: Lysis buffer A1 is 0.1mM KOH, 1mM EDTA, mix in the following proportions when using
组分Component 量①Amount
Lysis buffer A1Lysis buffer A1 33μl33μl
DTTDTT 3μl3μl
总量Total 36μl36μl
2、实验前准备2. Preparation before the experiment
设置一个65℃的水浴或金属浴加热器;Set up a 65℃ water bath or metal bath heater;
3.PCR仪的热盖温度设置为70℃。3. The temperature of the thermal lid of the PCR machine is set to 70°C.
实施例2、大肠杆菌细胞扩增Example 2. Amplification of E. coli cells
1.将0.5μl大肠杆菌细胞材料(所述细胞材料包括但不限于PBS重悬的细胞,水重悬的细胞,培养基重悬的细胞,乙醛固定的细胞,直接分离的单个细胞等)放到微型离心管中,加入样本体积0.5倍~20倍的矿物油(1倍为佳),充分震荡混匀。1. 0.5μl of E. coli cell material (the cell material includes but not limited to cells resuspended in PBS, cells resuspended in water, cells resuspended in culture medium, cells fixed with acetaldehyde, single cells directly isolated, etc.) Put it in a microcentrifuge tube, add 0.5 to 20 times the sample volume of mineral oil (1 times is better), shake and mix thoroughly.
2.加上同上述步骤1中油相预处理的样本等体积的Lysis buffer A,充分震荡混匀,并短暂离心。酶裂解,例如采用溶菌酶裂解,机械裂解与化学裂解的裂解效果一致。所述酶裂解包括但不限于SDS和溶菌酶,所述机械裂解包括热休克和超声裂解,且所述超声裂解的工作方法为在300~400w的裂解功率下,每次工作2~5s后间歇4~10s,总工作时间为6~10min。所述化学裂解液包括但不限于以下任一种:0.1mM KOH、1mM EDTA、1M DTT;50mM KAc、20mM Tris-Ac、10mM MgAc、 0.2%Trition X-100;1xPBS、1xThermo polbuffer、30mM Tris-HCl;10mM Tris-HCl、25mM EDTA、100mM NaCl;0.5%SDS、10mM Tris-HCl、50mM KCl;10mM Tris-HCl、100mM EDTA、0.5%SDS;30mM Tris-HCl、10mM EDTA、1%SDS;30mM Tris-HCl、2mM KCl、0.2%Triton X-100;尿素、碘乙酰胺和NH4HCO3。)最佳的为0.1mM KOH、1mM EDTA、1M DTT(PH=7-9)。2. Add the same volume of Lysis buffer A as the oil phase pretreatment sample in step 1 above, shake and mix thoroughly, and centrifuge briefly. Enzymatic lysis, such as lysozyme lysis, has the same effect of mechanical lysis and chemical lysis. The enzymatic lysis includes but is not limited to SDS and lysozyme, the mechanical lysis includes heat shock and ultrasonic lysis, and the working method of the ultrasonic lysis is at a lysis power of 300-400w, each time it works intermittently after 2-5s 4~10s, total working time is 6~10min. The chemical lysis solution includes but is not limited to any of the following: 0.1mM KOH, 1mM EDTA, 1M DTT; 50mM KAc, 20mM Tris-Ac, 10mM MgAc, 0.2% Trition X-100; 1xPBS, 1xThermopolbuffer, 30mM Tris- HCl; 10mM Tris-HCl, 25mM EDTA, 100mM NaCl; 0.5% SDS, 10mM Tris-HCl, 50mM KCl; 10mM Tris-HCl, 100mM EDTA, 0.5% SDS; 30mM Tris-HCl, 10mM EDTA, 1% SDS; 30mM Tris-HCl, 2mM KCl, 0.2% Triton X-100; Urea, iodoacetamide and NH4HCO3. ) The best is 0.1mM KOH, 1mM EDTA, 1M DTT (PH=7-9).
3. 65℃孵育10-15min。3. Incubate at 65°C for 10-15min.
4.加入同Lysis buffer等体积Neutralization buffer B,Neutralization buffer B由60mM KH2PO4和5mM K2HPO4配置。充分震荡混匀,并短暂离心,冰上储存。4. Add Neutralization buffer B with the same volume as Lysis buffer. Neutralization buffer B is configured by 60mM KH2PO4 and 5mM K2HPO4. Shake well and mix well, centrifuge briefly, and store on ice.
5.配制扩增混合液。混匀并短暂离心;5. Prepare the amplification mixture. Mix and centrifuge briefly;
DNA聚合酶包括但不限于vent DNA聚合酶、T7 DNA聚合酶、T4 DNA聚合酶、DNA聚合酶I、(Klenow)大片段、DNA聚合酶I(E.coli)、Sulfolobus DNA聚合酶IV、phi29 DNA聚合酶、Bst DNA聚合酶,Equiphi29 DNA聚合酶等,最佳的为Phi29 DNA聚合酶。置于冰上待用;其他试剂使用前需在室温溶解后震荡离心,置于冰上待用;ddH 2O置于室温待用;SCC-reaction buffer C1溶液可以由10%体积比的10×Phi29buffer、水、7.5%体积比的DMSO,10mM dNTP、引物总浓度为50μM的N6primers和1M DTT组成。可以按照表2配制扩增混合液。水(ddH 2O),SCC-reaction buffer C 1后,震荡混匀并离心后,加入Phi29DNA聚合酶。 DNA polymerases include but are not limited to vent DNA polymerase, T7 DNA polymerase, T4 DNA polymerase, DNA polymerase I, (Klenow) large fragments, DNA polymerase I (E.coli), Sulfolobus DNA polymerase IV, phi29 DNA polymerase, Bst DNA polymerase, Equiphi29 DNA polymerase, etc., the best is Phi29 DNA polymerase. Keep on ice for use; other reagents need to be dissolved at room temperature before shaking and centrifuge, and placed on ice for later use; ddH 2 O at room temperature for use; SCC-reaction buffer C1 solution can be 10% by volume 10× It consists of Phi29buffer, water, 7.5% DMSO by volume, 10mM dNTP, N6primers with a total primer concentration of 50μM, and 1M DTT. The amplification mixture can be prepared according to Table 2. After water (ddH 2 O), SCC-reaction buffer C 1 , shake and mix well and centrifuge, then add Phi29 DNA polymerase.
表2 扩增混合液的配制Table 2 Preparation of amplification mixture
Figure PCTCN2020131099-appb-000001
Figure PCTCN2020131099-appb-000001
6.在每个反应(3μl变性DNA,步骤5)中加入10μl反应混合液。6. Add 10 μl reaction mixture to each reaction (3 μl denatured DNA, step 5).
7. 30℃孵育8小时。7. Incubate at 30°C for 8 hours.
8. 65℃,10min灭活Phi29DNA聚合酶活性。8. Inactivate Phi29 DNA polymerase activity at 65°C for 10 min.
9.将扩增DNA稀释20倍,取其中1μl/反应作为模板,进行特定PCR检测分析。9. Dilute the amplified DNA 20 times, and take 1μl/reaction as a template for specific PCR detection and analysis.
10.将成功扩增的MDA产物进行纯化及二代测序。10. Purify and sequence the successfully amplified MDA product.
11.PCR分析,将扩增DNA稀释20倍,取其中1μl反应作为模板。11. For PCR analysis, the amplified DNA was diluted 20 times, and 1 μl of the reaction was used as a template.
为探讨添加样本扩增前经油相预处理对大肠杆菌细胞DNA扩增的影响,在用样本同体积的油相预处理的样本扩增获得的8个样本,及未进行样本油相预处理的8个样本按照标准程序扩增比较,其中每个样本中含有1个大肠杆菌细胞。根据1%的琼脂糖凝胶电泳分析MDA和PCR扩增产物发现,其中进行油相处理的样品中8个样品均呈阳性(即1%凝胶电泳检测出了典型的MDA和PCR条带),而标准方法扩增的样品只有5个呈阳性。此外,经油相前处理的样本中均成功地扩增了细菌基因片段,且没有发现污染,MDA反应得到了732-3,600ng产物,足够用于后续二代测序的制备。各选取5个成功扩增样品构建文库并用Illumina HiSeq2500进行测序。通过组装得到了10个单一扩增基因组(5个扩增时含油相,5个不含)(表3)。在无油相预处理样本的标准扩增条件下得到的基因组覆盖率为49.82%-52.60%,而经过油相预处理样本扩增的样品得到的基因组覆盖率明显增高,为89.78%~99.97%。In order to explore the effect of oil phase pretreatment on DNA amplification of Escherichia coli cells before amplification by adding samples, 8 samples obtained by amplifying samples with the same volume of oil phase pretreatment were used, and the samples were not pretreated with oil phase. According to the standard procedure, the 8 samples of the sample were amplified and compared, and each sample contained 1 E. coli cell. According to 1% agarose gel electrophoresis analysis of MDA and PCR amplification products, it was found that 8 samples of the oil phase treated samples were all positive (that is, 1% gel electrophoresis detected typical MDA and PCR bands) , While only 5 samples amplified by the standard method were positive. In addition, the bacterial gene fragments were successfully amplified in the samples pre-treated with the oil phase, and no contamination was found. The MDA reaction yielded 732-3,600ng product, which is sufficient for subsequent next-generation sequencing preparation. Each selected 5 successfully amplified samples to construct a library and sequenced with Illumina HiSeq2500. Through assembly, 10 single amplified genomes were obtained (5 contained oily phase when amplified and 5 did not contain) (Table 3). The genome coverage rate obtained under the standard amplification conditions of the oil-free pretreatment sample was 49.82%-52.60%, while the genome coverage rate of the sample amplified by the oil-phase pretreatment sample was significantly higher, 89.78% to 99.97% .
表3.大肠杆菌单细胞基因组的组装与评价Table 3. Assembly and evaluation of E. coli single-cell genome
Figure PCTCN2020131099-appb-000002
Figure PCTCN2020131099-appb-000002
实施例4、酿酒酵母细胞扩增Example 4 Saccharomyces cerevisiae cell expansion
1.将0.5μl酿酒酵母细胞材料(PBS重悬)放到微型离心管中,加入0.5μl矿物油充分震荡混匀。1. Put 0.5μl of Saccharomyces cerevisiae cell material (resuspended in PBS) into a microcentrifuge tube, add 0.5μl of mineral oil and shake well to mix.
2.加上1μl Lysis buffer A,充分震荡混匀,并短暂离心。2. Add 1μl Lysis buffer A, shake and mix thoroughly, and centrifuge briefly.
3. 65℃孵育10-15min。3. Incubate at 65°C for 10-15min.
4.加入1μl Neutralization buffer B。充分震荡混匀,并短暂离心,冰上储存。4. Add 1μl Neutralization buffer B. Shake well and mix well, centrifuge briefly, and store on ice.
5.按照表4配制扩增混合液。混匀并短暂离心;5. Prepare the amplification mixture according to Table 4. Mix and centrifuge briefly;
Phi29DNA聚合酶置于冰上待用;其他试剂使用前需在室温溶解后震荡离心,置于冰上待用;ddH 2O置于室温待用;可以按照表4配制扩增混合液。水(ddH 2O),SCC-reaction buffer C 1后,震荡混匀并离心后,加入Phi29DNA聚合酶。 Phi29DNA polymerase is placed on ice for use; other reagents need to be dissolved at room temperature before being shaken and centrifuged, and placed on ice for use; ddH 2 O is placed at room temperature for use; the amplification mixture can be prepared according to Table 4. After water (ddH 2 O), SCC-reaction buffer C 1 , shake and mix well and centrifuge, then add Phi29 DNA polymerase.
表4 扩增混合液的配制Table 4 Preparation of amplification mixture
Figure PCTCN2020131099-appb-000003
Figure PCTCN2020131099-appb-000003
②准备多个反应混合液,可以根据反应的个数额外多配制10%。②Prepare multiple reaction mixtures and prepare an additional 10% according to the number of reactions.
6.在每个反应(3μl变性DNA,步骤5)中加入10μl反应混合液。6. Add 10 μl reaction mixture to each reaction (3 μl denatured DNA, step 5).
7. 30℃孵育8小时。7. Incubate at 30°C for 8 hours.
8. 65℃,10min灭活Phi29DNA聚合酶活性。8. Inactivate the activity of Phi29 DNA polymerase at 65°C for 10 minutes.
9.将扩增DNA稀释20倍,取其中1μl/反应作为模板,进行特定PCR检测分析。9. Dilute the amplified DNA 20 times, and take 1μl/reaction as a template for specific PCR detection and analysis.
10.将成功扩增的MDA产物进行纯化及二代测序。10. Purify and sequence the successfully amplified MDA product.
11.PCR分析,将扩增DNA稀释20倍,取其中1μl反应作为模板。11. For PCR analysis, the amplified DNA was diluted 20 times, and 1 μl of the reaction was used as a template.
为探讨添加油相预处理样本对酿酒酵母细胞DNA扩增的影响,将8个经预处理的酿酒酵母细胞样本,与另外8个未经油相预处理样本按照标准程序进行扩增,其中每个样本中含有1个大肠杆菌细胞。根据1%的琼脂糖凝胶电泳分析MDA和PCR 扩增产物发现,其中经油相预处理的样本中8个样本呈阳性(即1%凝胶电泳检测出了典型的MDA和PCR条带),而未经油相预处理的样本经标准方法扩增的样本只有7个呈阳性。此外,经油相预处理样本中成功地扩增了细菌基因片段,且没有发现污染,MDA反应得到了998-4,020ng产物,足够用于后续二代测序的制备。接下来构建文库采用5个经油相预处理样本和5个未经油相预处理的样本进行扩增并用Illumina HiSeq2500进行测序。通过组装得到了10个单一扩增基因组(表5)。在未经油相预处理的样本的标准扩增条件下得到的基因组覆盖率为55.67%-67.80%,而经油相预处理样本扩增的样品得到的基因组覆盖率明显增高,为93.19%~99.89%。In order to explore the effect of adding oil-phase pretreatment samples on the DNA amplification of Saccharomyces cerevisiae cells, 8 pretreated Saccharomyces cerevisiae cell samples and the other 8 samples without oil phase pretreatment were amplified according to standard procedures. Each sample contains 1 E. coli cell. According to 1% agarose gel electrophoresis analysis of MDA and PCR amplification products, 8 samples of the samples pretreated with oil phase were positive (that is, 1% gel electrophoresis detected typical MDA and PCR bands) , While the samples that were not pre-treated with the oil phase were amplified by standard methods, only 7 samples were positive. In addition, the bacterial gene fragments were successfully amplified in the oil-phase pretreated samples, and no contamination was found. The MDA reaction yielded 998-4,020ng product, which is enough for subsequent next-generation sequencing preparation. Next, the library was constructed using 5 samples pretreated with oil phase and 5 samples without oil phase pretreatment for amplification and sequencing with Illumina HiSeq2500. Through assembly, 10 single amplified genomes were obtained (Table 5). The genome coverage of samples without oil phase pretreatment under standard amplification conditions is 55.67%-67.80%, while the genome coverage of samples amplified by oil phase pretreatment samples is significantly higher, reaching 93.19%~ 99.89%.
表5.酿酒酵母细胞单细胞基因组的组装与评价Table 5. Assembly and evaluation of single cell genome of Saccharomyces cerevisiae cells
Figure PCTCN2020131099-appb-000004
Figure PCTCN2020131099-appb-000004
实施例5、尿液样品细胞扩增Example 5, Urine sample cell expansion
1.将0.5μl尿液样品细胞材料(PBS重悬)放到微型离心管中,加入0.5μl 矿物油充分震荡混匀。1. Put 0.5μl of urine sample cell material (resuspended in PBS) into a microcentrifuge tube, add 0.5μl of mineral oil and shake well to mix.
2.加上1μl Lysis buffer A,充分震荡混匀,并短暂离心。2. Add 1μl Lysis buffer A, shake and mix thoroughly, and centrifuge briefly.
3. 65℃孵育10-15min。3. Incubate at 65°C for 10-15min.
4.加入1μl Neutralization buffer B。充分震荡混匀,并短暂离心,冰上储存。4. Add 1μl Neutralization buffer B. Shake well and mix well, centrifuge briefly, and store on ice.
5.冰上溶化Phi29DNA聚合酶。室温溶化其它试剂,震荡混匀并短暂离心。5. Melt Phi29 DNA polymerase on ice. Dissolve other reagents at room temperature, shake to mix and centrifuge briefly.
6.在每个反应(3μl变性DNA,步骤5)中加入10μl反应混合液。6. Add 10 μl reaction mixture to each reaction (3 μl denatured DNA, step 5).
7. 30℃孵育8小时。7. Incubate at 30°C for 8 hours.
8. 65℃,10min灭活Phi29DNA聚合酶活性。8. Inactivate the activity of Phi29 DNA polymerase at 65°C for 10 minutes.
9.将扩增DNA稀释20倍,取其中1μl/反应作为模板,进行特定PCR检测分析。9. Dilute the amplified DNA 20 times, and take 1μl/reaction as a template for specific PCR detection and analysis.
10.将成功扩增的MDA产物进行纯化及二代测序。10. Purify and sequence the successfully amplified MDA product.
11.PCR分析,将扩增DNA稀释20倍,取其中1μl反应作为模板。11. For PCR analysis, the amplified DNA was diluted 20 times, and 1 μl of the reaction was used as a template.
为探讨添加油相预处理样本对尿液样本细胞DNA扩增的影响,在1μl油相的存在下扩增了8个样本,另外8个样本按照标准程序扩增,其中每个样本中含有1个大肠杆菌细胞。根据1%的琼脂糖凝胶电泳分析MDA和PCR扩增产物发现,其中添加油相的样品中有8个样品呈阳性(即1%凝胶电泳检测出了典型的MDA和PCR条带),而标准方法扩增的样品只有6个呈阳性。在这些样本中成功地扩增了细菌基因片段,且没有发现污染,MDA反应得到了805-3,430ng产物,足够用于后续二代测序的制备。接下来构建文库并用Illumina HiSeq2500进行测序。通过组装得到了10个单一扩增基因组(5个扩增时含油相,5个不含)(表6)。在无油相的标准扩增条件下得到的基因组覆盖率为49.02%-57.60%,而含油相扩增的样品得到的基因组覆盖率明显增高,为92.18%~99.57%。In order to explore the effect of adding oil phase pretreatment samples on the DNA amplification of urine samples, 8 samples were amplified in the presence of 1 μl oil phase, and the other 8 samples were amplified according to standard procedures, and each sample contained 1 E. coli cells. According to 1% agarose gel electrophoresis analysis of MDA and PCR amplification products, it was found that 8 samples of the oil phase added samples were positive (that is, 1% gel electrophoresis detected typical MDA and PCR bands). Only 6 samples amplified by the standard method were positive. Bacterial gene fragments were successfully amplified in these samples, and no contamination was found. The MDA reaction yielded 805-3,430ng product, which was sufficient for subsequent preparation of next-generation sequencing. Next, the library was constructed and sequenced with Illumina HiSeq2500. Through assembly, 10 single amplified genomes were obtained (5 contained oily phase when amplified, 5 did not contain) (Table 6). The genome coverage rate obtained under standard amplification conditions without oil phase was 49.02%-57.60%, while the genome coverage rate obtained from the oily phase amplified samples was significantly higher, ranging from 92.18% to 99.57%.
实施例6.尿液样品细胞扩增Example 6. Urine sample cell expansion
除了步骤1中,把矿物油换成氟碳油外,其他步骤同实施例5。结果表明,含油扩增的样品得到的基因组覆盖率明显比对照高。Except that in step 1, the mineral oil is replaced with fluorocarbon oil, the other steps are the same as in Example 5. The results showed that the genome coverage of the oil-containing amplified samples was significantly higher than that of the control.
表6.尿液样本细胞单细胞基因组的组装与评价Table 6. Assembly and evaluation of single cell genome of urine samples
Figure PCTCN2020131099-appb-000005
Figure PCTCN2020131099-appb-000005

Claims (13)

  1. 一种单细胞基因组扩增的方法,其特征在于包括以下步骤:A method for single-cell genome amplification, which is characterized by comprising the following steps:
    a.将待扩增的单细胞样本重悬于油相中;a. Resuspend the single cell sample to be amplified in the oil phase;
    b.将上述a步骤获得的重悬于油相的细胞进行裂解;b. Lyse the cells resuspended in the oil phase obtained in step a above;
    c.上述b步骤获得的样本中,提供DNA聚合酶,引物,及其他扩增反应必需的试剂进行扩增反应。c. In the sample obtained in step b above, provide DNA polymerase, primers, and other necessary reagents for the amplification reaction to perform the amplification reaction.
  2. 如权利要求1所述的方法,其特征在于,所述油相选自矿物油、氟碳油、硅烷油中的任一种或其任意组合。The method according to claim 1, wherein the oil phase is selected from any one or any combination of mineral oil, fluorocarbon oil, and silane oil.
  3. 如权利要求2所述的方法,其特征在于,所述油相还包含表面活性剂,优选的,表面活性剂是span-80或EM90。The method of claim 2, wherein the oil phase further comprises a surfactant, preferably, the surfactant is span-80 or EM90.
  4. 如权利要求1所述的方法,其特征在于,单细胞样本与油相混合比例为1:0.5至1:20。The method of claim 1, wherein the mixing ratio of the single cell sample and the oil phase is 1:0.5 to 1:20.
  5. 如权利要求1所述的方法,其特征在于,所述的单细胞样本是通过激光辐射分选获得的样本。The method of claim 1, wherein the single-cell sample is a sample obtained by laser radiation sorting.
  6. 如权利要求4所述的方法,其特征在于,所述的激光辐射分选为拉曼信号分选。The method of claim 4, wherein the laser radiation sorting is Raman signal sorting.
  7. 如权利要求1所述的方法,其特征在于,b步骤中,所述的裂解选自化学裂解、酶裂解或机械裂解的任一种或其任意组合。The method of claim 1, wherein in step b, the cleavage is selected from any one of chemical cleavage, enzymatic cleavage, or mechanical cleavage, or any combination thereof.
  8. 如权利要求6所述的方法,其特征在于,所述的化学裂解为碱裂解。The method of claim 6, wherein the chemical lysis is alkaline lysis.
  9. 如权利要求1所述的方法,其特征在于,c步骤中所述的DNA聚合酶是Phi29DNA聚合酶。The method of claim 1, wherein the DNA polymerase in step c is Phi29 DNA polymerase.
  10. 一种用于单细胞基因组扩增的试剂盒,其特征在于,所述试剂盒包括:单细胞样本扩增前预处理液、DNA聚合酶,扩增缓冲液,引物;所述单细胞样本扩增前预处理液为油相。A kit for single-cell genome amplification, characterized in that the kit includes: a pretreatment solution before amplification of a single-cell sample, a DNA polymerase, an amplification buffer, and primers; the single-cell sample amplification The pretreatment liquid before the increase is the oil phase.
  11. 一种如10所述的试剂盒,其特征在于,所述的油相选自矿物油、氟碳油、硅烷油中的任一种或其任意组合。A kit according to 10, wherein the oil phase is selected from any one or any combination of mineral oil, fluorocarbon oil, and silane oil.
  12. 权利要求1至9中任一所述方法在基因组测序、全息阵列、定量PCR中的应用。The application of the method according to any one of claims 1 to 9 in genome sequencing, holographic array, and quantitative PCR.
  13. 权利要求10至12中任一所述试剂盒在测序、全息阵列、定量PCR中的应用。The application of the kit according to any one of claims 10 to 12 in sequencing, holographic array, and quantitative PCR.
PCT/CN2020/131099 2019-11-25 2020-11-24 Kit for single-cell whole-genome amplification and use thereof WO2021104252A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911166909.3A CN112831543B (en) 2019-11-25 2019-11-25 Single-cell whole genome amplification kit and application thereof
CN201911166909.3 2019-11-25

Publications (1)

Publication Number Publication Date
WO2021104252A1 true WO2021104252A1 (en) 2021-06-03

Family

ID=75922279

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/131099 WO2021104252A1 (en) 2019-11-25 2020-11-24 Kit for single-cell whole-genome amplification and use thereof

Country Status (2)

Country Link
CN (1) CN112831543B (en)
WO (1) WO2021104252A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012166425A2 (en) * 2011-05-27 2012-12-06 President And Fellows Of Harvard College Methods of amplifying whole genome of a single cell
US20130130919A1 (en) * 2011-10-18 2013-05-23 The Regents Of The University Of California Long-Range Barcode Labeling-Sequencing
WO2014193980A1 (en) * 2013-05-30 2014-12-04 The Regents Of The University Of California Substantially unbiased amplification of genomes
CN108273454A (en) * 2016-12-27 2018-07-13 中国科学院微生物研究所 A kind of method that nanoliter level microlayer model merges in small-sized reaction tube
CN108350488A (en) * 2015-08-17 2018-07-31 加利福尼亚大学董事会 Multiple displacement amplification (MDA) method based on droplet and compositions related
WO2019148119A1 (en) * 2018-01-29 2019-08-01 St. Jude Children's Research Hospital, Inc. Method for nucleic acid amplification

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012166425A2 (en) * 2011-05-27 2012-12-06 President And Fellows Of Harvard College Methods of amplifying whole genome of a single cell
US20130130919A1 (en) * 2011-10-18 2013-05-23 The Regents Of The University Of California Long-Range Barcode Labeling-Sequencing
WO2014193980A1 (en) * 2013-05-30 2014-12-04 The Regents Of The University Of California Substantially unbiased amplification of genomes
CN108350488A (en) * 2015-08-17 2018-07-31 加利福尼亚大学董事会 Multiple displacement amplification (MDA) method based on droplet and compositions related
CN108273454A (en) * 2016-12-27 2018-07-13 中国科学院微生物研究所 A kind of method that nanoliter level microlayer model merges in small-sized reaction tube
WO2019148119A1 (en) * 2018-01-29 2019-08-01 St. Jude Children's Research Hospital, Inc. Method for nucleic acid amplification

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MASAHITO HOSOKAWA, YOHEI NISHIKAWA, MASATO KOGAWA, HARUKO TAKEYAMA: "Massively parallel whole genome amplification for single-cell sequencing using droplet microfluidics", SCIENTIFIC REPORTS, vol. 7, no. 1, 1 December 2017 (2017-12-01), XP055672497, DOI: 10.1038/s41598-017-05436-4 *
QIANG ZHANG, TINGTING WANG, QIAN ZHOU, PENG ZHANG, YANHAI GONG, HONGLEI GOU, JIAN XU, BO MA: "Development of a facile droplet-based single-cell isolation platform for cultivation and genomic analysis in microorganisms", SCIENTIFIC REPORTS, vol. 7, no. 1, 1 December 2017 (2017-12-01), XP055518191, DOI: 10.1038/srep41192 *

Also Published As

Publication number Publication date
CN112831543B (en) 2023-08-29
CN112831543A (en) 2021-05-25

Similar Documents

Publication Publication Date Title
CN109837328B (en) Nucleic acid detection method
CN112941155B (en) DNA primer pair with stem-loop structure and application thereof
Westermann et al. Host-pathogen transcriptomics by dual RNA-Seq
Gao et al. RT-qPCR based quantitative analysis of gene expression in single bacterial cells
US7361465B2 (en) Methods and compositions for tailing and amplifying RNA
Ortmann et al. Transcriptome analysis of infection of the archaeon Sulfolobus solfataricus with Sulfolobus turreted icosahedral virus
WO2020168710A1 (en) Constant temperature nucleic acid detection and analysis method based on cas9 nicking enzyme-coupled dna polymerase
WO2022077687A1 (en) Novel crispr nucleic acid testing method and use
WO2023217291A1 (en) Polymerase mutant and use thereof
CN112094888A (en) Multifunctional buffer solution and application thereof
Wang et al. Rapid and ultrasensitive detection of methicillin-resistant Staphylococcus aureus based on CRISPR-Cas12a combined with recombinase-aided amplification
CN114561374A (en) Novel thermophilic endonuclease mutant and preparation method and application thereof
Li et al. Mesophilic Argonaute-based isothermal detection of SARS-CoV-2
JP2021104046A (en) Method for isolating nucleic acid from analyte in preservative for liquid type cell diagnosis including formaldehyde
WO2023207909A1 (en) Crispr-based nucleic acid detection kit and use thereof
Fang et al. Depletion of ribosomal RNA sequences from single‐cell RNA‐sequencing library
WO2021104252A1 (en) Kit for single-cell whole-genome amplification and use thereof
US20070202522A1 (en) Isothermal screening of tumor cell related nucleic acids
Fujii et al. Error-prone rolling circle amplification greatly simplifies random mutagenesis
CN112280832B (en) Extraction-free nucleic acid detection method and kit
Bonar et al. E. coli 6S RNA complexed to RNA polymerase maintains product RNA synthesis at low cellular ATP levels by initiation with noncanonical initiator nucleotides
Cecchetelli Finding nucleic acids with SHERLOCK and DETECTR
US20090170064A1 (en) Isothermal screening of human papillomavirus related nucleic acids
CN112553378B (en) Reagent and kit for detecting 2019-nCoV and application
CN108588202A (en) A kind of unicellular full genome amplification method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20893670

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20893670

Country of ref document: EP

Kind code of ref document: A1